Form 4: Avanos Medical Director Indrani Franchini Acquires Shares Through Restricted Stock Units

Director Indrani Franchini acquired 12,003 shares of Avanos Medical, Inc. through restricted stock units on January 2, 2025.

Summary

• Indrani Franchini, a director at Avanos Medical, Inc., acquired 12,003 shares of common stock on January 2, 2025.
• These shares were granted as restricted stock units under the company's Outside Directors' Compensation Plan.
• The transaction did not involve any monetary payment by the director, as the price per share was $0.
• Following this transaction, Ms. Franchini's total direct holdings in Avanos Medical, Inc. increased to 16,820 shares.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects a standard compensation practice and shows director alignment with company performance.

Positives

• The acquisition of shares by a director demonstrates confidence in the company's future prospects.
• The use of restricted stock units aligns the director's interests with those of the shareholders.

Industry Context

This is a standard transaction for directors of publicly traded companies, often used as part of their compensation packages to align their interests with shareholders.

Comparison to Industry Standards

• The use of restricted stock units as part of director compensation is a common practice among publicly traded companies.
• Many companies in the medical device industry use similar compensation plans to incentivize their directors.
• The number of shares granted is within the typical range for director compensation packages.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns director interests with company performance.

Key Dates

Keywords

Avanos Medical, Director, Indrani Franchini, Restricted Stock Units, Share Acquisition, Insider Trading, Form 4